GoHealth (NASDAQ:GOCO) Issues Earnings Results

GoHealth (NASDAQ:GOCO) announced its quarterly earnings data on Monday. The company reported ($2.36) earnings per share for the quarter, beating analysts’ consensus estimates of ($2.40) by $0.04, FiscalAI reports. GoHealth had a negative return on equity of 33.29% and a negative net margin of 71.06%.The company had revenue of $11.91 million for the quarter, compared to analyst estimates of $16.90 million.

GoHealth Price Performance

Shares of NASDAQ:GOCO opened at $0.86 on Tuesday. GoHealth has a 12 month low of $0.83 and a 12 month high of $7.12. The firm has a market capitalization of $24.88 million, a price-to-earnings ratio of -0.05 and a beta of 1.33. The business’s 50 day simple moving average is $1.30 and its 200-day simple moving average is $2.05.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. Redwood Capital Management LLC acquired a new position in shares of GoHealth during the 3rd quarter worth approximately $4,455,000. Geode Capital Management LLC raised its position in shares of GoHealth by 8.1% during the 4th quarter. Geode Capital Management LLC now owns 150,821 shares of the company’s stock worth $324,000 after purchasing an additional 11,340 shares during the last quarter. Corient Private Wealth LLC raised its position in shares of GoHealth by 7.7% during the 2nd quarter. Corient Private Wealth LLC now owns 125,938 shares of the company’s stock worth $699,000 after purchasing an additional 8,979 shares during the last quarter. Barclays PLC raised its position in shares of GoHealth by 10.1% during the 4th quarter. Barclays PLC now owns 81,181 shares of the company’s stock worth $175,000 after purchasing an additional 7,430 shares during the last quarter. Finally, Focus Partners Wealth acquired a new position in shares of GoHealth during the 3rd quarter worth approximately $270,000. 24.21% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the company. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of GoHealth in a report on Friday, April 24th. Freedom Capital lowered GoHealth from a “strong-buy” rating to a “hold” rating in a report on Monday, April 6th. Finally, Noble Financial raised GoHealth to a “strong-buy” rating in a report on Wednesday, April 1st. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $5.00.

GoHealth Company Profile

GoHealth, Inc is a technology-driven health insurance marketplace that connects consumers with a wide range of health insurance plans from leading carriers. Through its digital platform, the company facilitates the comparison, selection and enrollment process for individual and family plans, as well as Medicare Advantage and Medicare Supplement products. By leveraging data analytics and customer support services, GoHealth aims to simplify a traditionally complex market and enable more informed decision-making for policyholders.

The company’s online portal integrates real-time quoting tools, educational resources and access to licensed insurance agents, ensuring that users receive personalized guidance throughout the enrollment journey.